-
公开(公告)号:SI3220137T1
公开(公告)日:2019-05-31
申请号:SI201630237
申请日:2016-03-14
Applicant: HOFFMANN LA ROCHE , HOFFMANN LA ROCHE
Inventor: RINGEMANN CHRISTIAN , WIEDER HERBERT
-
公开(公告)号:CA3000297C
公开(公告)日:2021-11-02
申请号:CA3000297
申请日:2016-11-21
Applicant: HOFFMANN LA ROCHE
Inventor: IBACH ALEXANDER , RINGEMANN CHRISTIAN , STEPHAN PETER
Abstract: The invention concerns a method and an apparatus for determining the concentration of an analyte in a body fluid, where the following measures are proposed: providing a layered test element (12) including an enzyme-based chemistry layer which is responsive to the analyte by a color change, applying a sample of the body fluid onto the test element (12), detecting by means of a photometric reflectance measuring device (16) a reflectance value of the test element (12), correcting the measured reflectance value by a predetermined offset value attributed to the test element (12), determining a concentration value of the analyte using the offset- corrected reflectance value.
-
公开(公告)号:CA3025906A1
公开(公告)日:2017-12-07
申请号:CA3025906
申请日:2017-05-09
Applicant: HOFFMANN LA ROCHE
Inventor: DUKE DAVID L , GREENBURG ALAN , RINGEMANN CHRISTIAN , MANOHAR CHINMAY UDAY
Abstract: A method and system of determining a basal rate adjustment of insulin in a continuous glucose monitoring system of a person with diabetes is provided. The method includes receiving, by at least one computing device, a signal representative of at least one glucose measurement; detecting, by the at least one computing device, a glucose state of the person based on the signal, the detected glucose state including a glucose level of the person and a rate of change of the glucose level; determining, by the at least one computing device, a current risk metric, the current risk metric indicating a risk of at least one of a hypoglycemic condition and a hyperglycemic condition of the person; and calculating, by the at least one computing device, an adjustment to a basal rate of a therapy delivery device based on the current risk metric and a control-to-range algorithm comprising at least one aggressiveness parameter.
-
公开(公告)号:CA3000297A1
公开(公告)日:2017-06-01
申请号:CA3000297
申请日:2016-11-21
Applicant: HOFFMANN LA ROCHE
Inventor: IBACH ALEXANDER , RINGEMANN CHRISTIAN , STEPHAN PETER
Abstract: The invention concerns a method and an apparatus for determining the concentration of an analyte in a body fluid, where the following measures are proposed: providing a layered test element (12) including an enzyme-based chemistry layer which is responsive to the analyte by a color change, applying a sample of the body fluid onto the test element (12), detecting by means of a photometric reflectance measuring device (16) a reflectance value of the test element (12), correcting the measured reflectance value by a predetermined offset value attributed to the test element (12), determining a concentration value of the analyte using the offset- corrected reflectance value.
-
5.
公开(公告)号:PL3242233T3
公开(公告)日:2022-08-01
申请号:PL16168149
申请日:2016-05-03
Applicant: HOFFMANN LA ROCHE
Inventor: RINGEMANN CHRISTIAN , STEIGER BERND
-
公开(公告)号:HUE057491T2
公开(公告)日:2022-05-28
申请号:HUE17725002
申请日:2017-05-09
Applicant: HOFFMANN LA ROCHE
Inventor: DUKE DAVID L , GREENBURG ALAN , RINGEMANN CHRISTIAN , MANOHAR CHINMAY UDAY
-
公开(公告)号:ES2720780T3
公开(公告)日:2019-07-24
申请号:ES16160136
申请日:2016-03-14
Applicant: HOFFMANN LA ROCHE
Inventor: RINGEMANN CHRISTIAN , WIEDER HERBERT
IPC: G01N27/327 , C12Q1/00
Abstract: Un método para detectar una contribución interferente utilizando un modo de detección de interferente dentro de un biosensor, en el que el biosensor tiene un primer electrodo (112), un segundo electrodo y un tercer electrodo (114), en donde el primer electrodo (112) y el segundo electrodo están cubiertos por una membrana, en donde el primer electrodo (112) incluye además una enzima o en donde el primer electrodo (112) está cubierto por una capa de enzima, en donde el primer electrodo (112), el segundo electrodo y el tercero electrodo (114) están conectados mediante un potenciostato, en el que, en un modo de funcionamiento normal, a través del potenciostato, se aplica una diferencia de potencial eléctrico entre el primer electrodo (112). y el segundo electrodo de manera que el primer electrodo (112) permite procesos oxidativos y el tercer electrodo (114) permite procesos reductivos, el método comprende los pasos de: a) cambiar del modo operativo normal al modo de detección interferente , en el que, en el modo de detección de interferente, la diferencia de potencial eléctrico entre el primer electrodo (112) y el segundo electrodo se altera por un período de tiempo limitado de una manera que el tercer electrodo (114) permite procesos oxidativos; b) medir una característica de corriente-voltaje (110) del tercer electrodo (114); y c) determinar la contribución interferente mediante la evaluación de la característica de corriente-voltaje (110) del tercer electrodo (114).
-
公开(公告)号:AU2017275392A1
公开(公告)日:2019-01-03
申请号:AU2017275392
申请日:2017-05-09
Applicant: HOFFMANN LA ROCHE
Inventor: DUKE DAVID L , GREENBURG ALAN , RINGEMANN CHRISTIAN , MANOHAR CHINMAY UDAY
Abstract: A method and system of determining a basal rate adjustment of insulin in a continuous glucose monitoring system of a person with diabetes is provided. The method includes receiving, by at least one computing device, a signal representative of at least one glucose measurement; detecting, by the at least one computing device, a glucose state of the person based on the signal, the detected glucose state including a glucose level of the person and a rate of change of the glucose level; determining, by the at least one computing device, a current risk metric, the current risk metric indicating a risk of at least one of a hypoglycemic condition and a hyperglycemic condition of the person; and calculating, by the at least one computing device, an adjustment to a basal rate of a therapy delivery device based on the current risk metric and a control-to-range algorithm comprising at least one aggressiveness parameter.
-
公开(公告)号:HUE034313T2
公开(公告)日:2018-02-28
申请号:HUE13811932
申请日:2013-12-19
Applicant: HOFFMANN LA ROCHE
Inventor: AIGNER SIMON , CHEMNITIUS GABRIELE , HORN CARINA , LIMBURG BERND , OTTENSTEIN TIMO , PETRICH WOLFGANG , PLUM MARKUS , RINGEMANN CHRISTIAN , SERR MARKUS
-
公开(公告)号:CA3025874A1
公开(公告)日:2017-12-07
申请号:CA3025874
申请日:2017-05-09
Applicant: HOFFMANN LA ROCHE
Inventor: DUKE DAVID L , RINGEMANN CHRISTIAN , MANOHAR CHINMAY UDAY , GREENBURG ALAN
Abstract: Methods and systems are disclosed for determining a basal rate adjustment of insulin based on risk associated with a glucose state of a person with diabetes. A method may include detecting a glucose state of the person based on a received glucose measurement signal and determining a current risk metric associated with the detected glucose state. The method may include determining a current risk metric associated with the detected glucose state based on a weighted average of cumulative hazard values of return paths generated from a glucose state distribution around a detected glucose state. The method may include calculating an adjustment to a basal rate of a therapy delivery device based on the current risk metric associated with the detected glucose state and a reference risk metric associated with a reference glucose level.
-
-
-
-
-
-
-
-
-